Michael A. Jerman
Equibles does not estimate personal net worth.
About Michael A. Jerman
Earlier roles on record: Board Member at Alaunos Therapeutics, Inc. (TCRT) until October 13, 2026. Alaunos Therapeutics, Inc. reported in an 8-K filed October 13, 2026 that Michael A. Jerman resigned as director. Alaunos Therapeutics, Inc. reported in an 8-K filed July 17, 2025 that Michael A. Jerman was appointed director, effective July 15, 2025.
“In accordance with the Merger Agreement, on October 13, 2026, each of Robert W. Postma, Michael A. Jerman and Jaime W. Vieser delivered resignations that will become effective automatically only upon, and subject to, stockholder approval of the Conversion Proposal.”
“On July 15, 2025, the board of directors (the "Board") of Alaunos Therapeutics, Inc. (the "Company") appointed Mr. Michael A. Jerman, as a director of the Company effective immediately.”
Affiliation history
-
2025-07-15–2026-10-13